Advertisement
UK markets close in 2 hours 21 minutes
  • FTSE 100

    8,066.28
    +25.90 (+0.32%)
     
  • FTSE 250

    19,655.39
    -63.98 (-0.32%)
     
  • AIM

    754.19
    -0.50 (-0.07%)
     
  • GBP/EUR

    1.1669
    +0.0024 (+0.21%)
     
  • GBP/USD

    1.2473
    +0.0011 (+0.09%)
     
  • Bitcoin GBP

    50,593.83
    -2,444.99 (-4.61%)
     
  • CMC Crypto 200

    1,350.40
    -32.17 (-2.33%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,342.50
    +4.10 (+0.18%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,900.68
    -188.02 (-1.04%)
     
  • CAC 40

    7,979.63
    -112.23 (-1.39%)
     

Analysts’ Recommendations for Colgate-Palmolive, Post-Q2 Results

Analysts’ Recommendations for Colgate-Palmolive, Post-Q2 Results

Colgate-Palmolive’s (CL) performance was less than impressive in the first half of this year, and its second-quarter sales and earnings growth decelerated. Analysts expect headwinds to continue to hurt the company’s sales and earnings in the near term, and have maintained mostly neutral recommendations. Following its second-quarter results, Jefferies lowered its target price on CL stock to $60 from $62.